Author

Evelyn Nunes Goulart da Silva Pereira

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Will GLP-1-based therapies reshape the epidemiology of MASLD? An emerging public health perspective

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease worldwide, driven by increasing obesity and type 2 diabetes mellitus. The expanding use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) raises an epidemiological question: could therapies targeting the...

Evelyn Nunes Goulart da Silva Pereira, Karine Lino Rodrigues · Frontiers in Endocrinology · 0 citations

Open access Oct 2026

Mechanistic insights into cholesterol-mediated MASH pathogenesis: Glycation, lipoxidation, and RAGE pathway.

Findings identify dietary cholesterol as a key modulator of MASH, supporting a functional contribution of RAGE signaling to cholesterol-associated disease severity.

Beatriz Peres de Araujo, R. R. Silvares, Evelyn Nunes Goulart da Silva Pereira et al. · Biomedicine & pharmacotherap... · 0 citations